Cas no 84680-75-1 (Astragaloside I)

Astragaloside I structure
Astragaloside I structure
Product Name:Astragaloside I
CAS No:84680-75-1
MF:C45H72O16
MW:869.0435962677
MDL:MFCD30478908
CID:60749
PubChem ID:329824950
Update Time:2024-10-26

Astragaloside I Chemical and Physical Properties

Names and Identifiers

    • Astragaloside I
    • 3-O-β-(2',3'-di-O-acetyl)-D-xylopyranosyl-6-O-β-D-glucopyranosyl-cycloastragenol
    • ASTRAGALOSIDE I(SH)
    • ASTRAGALOSIDEⅠ
    • b-D-Glucopyranoside, (3b,6a,16b,20R,24S)-3-[(2,3-di-O-acetyl-b-D-xylopyranosyl)oxy]-20,24-epoxy-16,25-dihydroxy-9,19-cyclolanostan-6-yl
    • 2,5-Bis[1-(1,1-dimethyl-2-propenyl)-1H-indol-3-yl]-3,6-dimethoxy-2,5-cyclohexadiene-1,4-dione
    • 2,5-bis[1-(1,1-dimethylallyl)-1H-indol-3-yl]-3,6-dimethoxy-1,4-benzo
    • 2,5-bis-[1-(1,1-dimethyl-allyl)-indol-3-yl]-3,6-dimethoxy-[1,4]benzoquinone
    • 2,5-dimethoxy-3,6-bis[1-(2-methylbut-3-en-2-yl)-1H-indol-3-yl]cyclohexa-2,5-diene-1,4-dione
    • Asterrichinon-dimethylether
    • asterriquinone dimethyl ether
    • Astrasieversianin IV
    • Cyclosieversioside B
    • cyclosiversioside B
    • (3β,6α,16β,20R,24S)-3-[(2,3-Di-O-acetyl-β-D-xylopyranosyl)oxy]-20,24-epoxy-16,25-dihydroxy-9,19-cyclolanostan-6-yl β-D-glucopyranoside
    • AstragalosideI
    • Astragaloside-I
    • C43H68O16
    • X1090
    • ASTRAGALOSIDE cent inverted exclamation mark
    • 680A751
    • 3-O--(2\\',3\\'-di-O-acetyl)-D-xylopyranosyl-6-O--D-glucopyranosyl-cycloastragenol
    • [(2S,3R,4S,5R)-3-Acetyloxy-5-hydroxy-2-[[(1R,3R,6S,9S,11S,12S,14S,15R,16R)-14-hydroxy-15-[(2R,5S)-5-
    • CID 51346122
    • (3β,6α,16β,20R,24S)-3-[(2,3-Di-O-acetyl-β-D-xylopyranosyl)oxy]-20,24-epoxy-16,25-dihydroxy-9,19-cyclolanostan-6-yl β-D-glucopyranoside (ACI)
    • 1H,19H-Cyclopropa[9,10]cyclopenta[a]phenanthrene, β-D-glucopyranoside deriv. (ZCI)
    • 9,19-Cyclolanostane, β-D-glucopyranoside deriv. (ZCI)
    • s9014
    • CS-3711
    • UNII-24CT26I88H
    • 24CT26I88H
    • (3beta,6alpha,9beta,16beta,20R,24S)-3-[(2,3-di-O-acetyl-beta-D-xylopyranosyl)oxy]-16,25-dihydroxy-20,24-epoxy-9,19-cyclolanostan-6-yl beta-D-glucopyranoside
    • Astragaloside I (constituent of astragalus)
    • beta-D-Glucopyranoside, (3beta,6alpha,16beta,20R,24S)-3-[(2,3-di-O-acetyl-beta-D-xylopyranosyl)oxy]-20,24-epoxy-16,25-dihydroxy-9,19-cyclolanostan-6-yl-
    • (3beta,6alpha,16beta,20R,24S)-3-[(2,3-Di-O-acetyl-beta-D-xylopyranosyl)oxy]-20,24-epoxy-16,25-dihydroxy-9,19-cyclolanostan-6-yl beta-D-glucopyranoside
    • (3beta,6alpha,9beta,16beta,20R,24S)-3-((2,3-di-O-acetyl-beta-D-xylopyranosyl)oxy)-16,25-dihydroxy-20,24-epoxy-9,19-cyclolanostan-6-yl beta-D-glucopyranoside
    • AKOS030526921
    • Q27163025
    • 91739-00-3
    • beta-D-Glucopyranoside, (3beta,6alpha,16beta,20R,24S)-3-((2,3-di-O-acetyl-beta-D-xylopyranosyl)oxy)-20,24-epoxy-16,25-dihydroxy-9,19-cyclolanostan-6-yl
    • HY-N0432
    • AS-56628
    • Astragaloside I, >=97% (HPLC)
    • [(2S,3R,4S,5R)-3-acetyloxy-5-hydroxy-2-[[(1S,3R,6S,8R,9S,11S,12S,14S,15R,16R)-14-hydroxy-15-[(2R,5S)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-7,7,12,16-tetramethyl-9-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-pentacyclo[9.7.0.01,3.03,8.012,16]octadecanyl]oxy]oxan-4-yl] acetate
    • CHEBI:91024
    • Astragaloside I (constituent of astragalus) [DSC]
    • C17797
    • Astragaloside I,98%
    • A-D-xylopyranosyl)oxy]-20,24-epoxy-16,25-dihydroxy-9,19-cyclolanostan-6-yl
    • A,6
    • LS-15453
    • A,20R,24S)-3-[(2,3-Di-O-acetyl-
    • 84680-75-1
    • A-D-glucopyranoside
    • PD065122
    • [(2S,3R,4S,5R)-3-acetyloxy-5-hydroxy-2-[[(1R,3R,6S,9S,11S,12S,14S,15R,16R)-14-hydroxy-15-[(2R,5S)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]-12,16-dimethyl-9-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6-pentacyclo[9.7.0.0^{1,3.0^{3,8.0^{12,16]octadecanyl]oxy]oxan-4-yl] acetate
    • A,16
    • (3
    • Astragaloside?
    • 20,24-EPOXYCYCLOARTANE-3,16,25-TRIOL-6-O-BETA-D-GLUCOPYRANOSIDE
    • Astragaloside I (Astrasieversianin IV
    • Astragaloside l, 98%, from Astragalus membranaceus Bunge
    • MDL: MFCD30478908
    • Inchi: 1S/C45H72O16/c1-21(47)56-33-24(50)19-55-38(34(33)57-22(2)48)60-28-11-13-45-20-44(45)15-14-41(7)35(43(9)12-10-29(61-43)40(5,6)54)23(49)17-42(41,8)27(44)16-25(36(45)39(28,3)4)58-37-32(53)31(52)30(51)26(18-46)59-37/h23-38,46,49-54H,10-20H2,1-9H3/t23-,24+,25-,26+,27-,28-,29-,30+,31-,32+,33-,34+,35-,36-,37+,38-,41+,42-,43+,44-,45+/m0/s1
    • InChI Key: KXHCYYSIAXMSPA-OOCCOBHWSA-N
    • SMILES: C[C@@]12C[C@H](O)[C@H]([C@]3(CC[C@@H](C(O)(C)C)O3)C)[C@@]1(C)CC[C@@]13C[C@]41CC[C@H](O[C@@H]1OC[C@@H](O)[C@H](OC(=O)C)[C@H]1OC(=O)C)C(C)(C)[C@@H]4[C@H](C[C@@H]23)O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1

Computed Properties

  • Exact Mass: 840.45100
  • Monoisotopic Mass: 840.451
  • Isotope Atom Count: 0
  • Hydrogen Bond Donor Count: 7
  • Hydrogen Bond Acceptor Count: 16
  • Heavy Atom Count: 59
  • Rotatable Bond Count: 11
  • Complexity: 1610
  • Covalently-Bonded Unit Count: 1
  • Defined Atom Stereocenter Count: 20
  • Undefined Atom Stereocenter Count : 1
  • Defined Bond Stereocenter Count: 0
  • Undefined Bond Stereocenter Count: 0
  • XLogP3: 1.6
  • Topological Polar Surface Area: 240
  • Molecular Weight: 841.0

Experimental Properties

  • Color/Form: Powder
  • Density: 1.39
  • Melting Point: No data available
  • Boiling Point: 910.64 °C at 760 mmHg
  • Flash Point: 265.49 °C
  • Refractive Index: 1.603
  • Solubility: 甲醇(微量)、吡啶(微量)
  • PSA: 240.36000
  • LogP: 1.22960
  • pka: 12.87±0.70(Predicted)

Astragaloside I Pricemore >>

Related Categories No. Product Name Cas No. Purity Specification Price update time Inquiry
SHANG HAI XIAN DING Biotechnology Co., Ltd.
L-HN097-5mg
Astragaloside I
84680-75-1 ,≥98%
5mg
¥471.0 2022-09-28
MedChemExpress
HY-N0432-10mM*1mLinDMSO
Astragaloside I
84680-75-1 ≥98.0%
10mM*1mLinDMSO
¥1721 2022-05-18
MedChemExpress
HY-N0432-5mg
Astragaloside I
84680-75-1 ≥98.0%
5mg
¥600 2025-04-15
MedChemExpress
HY-N0432-10mg
Astragaloside I
84680-75-1 ≥98.0%
10mg
¥1000 2025-04-15
MedChemExpress
HY-N0432-50mg
Astragaloside I
84680-75-1 ≥98.0%
50mg
¥3200 2025-04-15
MedChemExpress
HY-N0432-100mg
Astragaloside I
84680-75-1 ≥98.0%
100mg
¥5400 2025-04-15
SHANG HAI A LA DING SHENG HUA KE JI GU FEN Co., Ltd.
A115718-20mg
Astragaloside I
84680-75-1 ,≥98%
20mg
¥1190.90 2023-09-04
HE FEI BO MEI SHENG WU KE JI YOU XIAN ZE REN GONG SI
BZP0071-20mg
Astragaloside I
84680-75-1 HPLC≥98%
20mg
¥1000元 2023-09-15
ChemScence
CS-3711-5mg
Astragaloside I
84680-75-1 ≥98.0%
5mg
$100.0 2022-04-26
ChemScence
CS-3711-10mg
Astragaloside I
84680-75-1 ≥98.0%
10mg
$180.0 2022-04-26

Astragaloside I Production Method

Production Method 1

Reaction Conditions
1.1 Solvents: Water ;  48 h, rt
Reference
Microbial transformation of astragalosides to astragaloside IV by Absidia corymbifera AS2
Ye, Li; et al, Process Biochemistry (Amsterdam, 2011, 46(9), 1724-1730

Astragaloside I Raw materials

Astragaloside I Preparation Products

Recommended suppliers
上海嶸奧生物技術(shù)有限公司
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
上海嶸奧生物技術(shù)有限公司
Hubei Cuiyuan Biotechnology Co.,Ltd
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
Hubei Cuiyuan Biotechnology Co.,Ltd
Shanghai Hongxiang Biomedical Technology Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Shanghai Hongxiang Biomedical Technology Co., Ltd.
Nanjing jingzhu bio-technology Co., Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Bulk
Nanjing jingzhu bio-technology Co., Ltd.
Zhangzhou Sinobioway Peptide Co.,Ltd.
Gold Member
Audited Supplier Audited Supplier
CN Supplier
Reagent
Zhangzhou Sinobioway Peptide Co.,Ltd.